Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China flag China · Delayed Price · Currency is CNY
5.78
+0.05 (0.87%)
At close: Sep 30, 2026

SHA:688373 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,7933,9603,2374,2795,805-
Market Cap Growth
-31.13%22.34%-24.35%-26.30%--
Enterprise Value
3,7603,8412,8003,4434,701-
Last Close Price
5.786.044.946.538.86-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
23.0827.9324.8547.13120.42-
PB Ratio
23.2819.277.375.134.78-
P/TBV Ratio
23.3719.367.405.144.79-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
22.8827.0921.5037.9397.53-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
2.211.850.690.270.190.37
Net Debt / Equity Ratio
-0.20-0.35-0.66-0.88-0.86-0.71
Net Debt / EBITDA Ratio
0.230.290.671.674.061.16
Net Debt / FCF Ratio
0.280.340.652.174.121.53
Asset Turnover
0.240.180.130.070.050.01
Inventory Turnover
0.480.420.500.560.540.09
Quick Ratio
1.802.273.057.1411.135.03
Current Ratio
2.172.773.537.7211.915.41
Return on Equity (ROE)
-58.99%-74.98%-69.24%-41.12%-26.66%-42.75%
Return on Assets (ROA)
-13.21%-19.88%-27.18%-20.63%-15.00%-25.55%
Return on Capital Employed (ROCE)
-39.50%-51.40%-68.90%-42.60%-18.60%-48.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.70%-6.10%-13.62%-9.84%-3.79%-
FCF Yield
-3.06%-5.32%-13.84%-7.87%-4.34%-
Buyback Yield / Dilution
4.13%0.73%-0.33%-13.09%-10.17%-106.16%